Evaluation of the Lifetime Benefits of Metformin and SGLT2 Inhibitors in Type 2 Diabetes Mellitus Patients with Cardiovascular Disease: A Systematic Review and Two-Stage Meta-Analysis
Article in American Journal of Cardiovascular Drugs (April 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Article in American Journal of Cardiovascular Drugs (April 2024)
Article in Clinical Epidemiology (April 2024)
Article in JAMA Network Open (March 2024)